Medicare Enrolled
Dr. Satyen Mehta, MD
Hematology & Oncology · Cartersville, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mehta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mehta?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mehta
Dr. Satyen Mehta is a hematology & oncology specialist in Cartersville, GA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Mehta performed 717 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mehta received a total of $5,427 from 58 pharmaceutical and/or device companies across 290 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mehta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 50% volume in GA
$5,427 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗717
Medicare services
Top 50% in GA for hematology & oncology
Not available
Unique patients (not deduplicated)
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
191 | $95 | $260 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
142 | $112 | $386 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
126 | $47 | $198 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
113 | $72 | $283 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
40 | $64 | $179 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
31 | $135 | $455 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
27 | $87 | $336 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
24 | $97 | $372 |
| New patient office visit, complex (60-74 min) | 23 | $133 | $481 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$5,427
Total received (2018-2024)
Avg $775/year across 7 years
Top 43% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
290
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,475
2023
$1,107
2022
$1,017
2021
$378
2020
$485
2019
$588
2018
$378
Payments by company (2024)
ABBVIE INC.
$216
Genentech USA, Inc.
$148
Daiichi Sankyo Inc.
$136
PFIZER INC.
$119
Merck Sharp & Dohme LLC
$107
AstraZeneca Pharmaceuticals LP
$81
E.R. Squibb & Sons, L.L.C.
$68
GlaxoSmithKline, LLC.
$58
Exelixis Inc.
$52
Genmab U.S., Inc.
$49
Gilead Sciences, Inc.
$47
BeiGene USA, Inc.
$45
Regeneron Healthcare Solutions, Inc.
$34
Stemline Therapeutics Inc.
$30
Eisai Inc.
$28
Acrotech Biopharma Inc.
$27
PharmaEssentia USA Corporation
$26
Ipsen Biopharmaceuticals, Inc
$25
Mirati Therapeutics, Inc.
$24
PUMA BIOTECHNOLOGY, INC.
$23
Takeda Pharmaceuticals U.S.A., Inc.
$22
Astellas Pharma US Inc
$21
Novartis Pharmaceuticals Corporation
$21
Janssen Biotech, Inc.
$17
Deciphera Pharmaceuticals Inc.
$17
Alexion Pharmaceuticals, Inc.
$17
Karyopharm Therapeutics Inc.
$15
Top 3 companies account for 33.9% of 2024 payments
All-time payments by company (2018-2024) ›
Daiichi Sankyo Inc.
$452
Genentech USA, Inc.
$445
PFIZER INC.
$383
Novartis Pharmaceuticals Corporation
$321
AstraZeneca Pharmaceuticals LP
$306
ABBVIE INC.
$288
Janssen Biotech, Inc.
$225
Amgen Inc.
$220
Celgene Corporation
$218
Merck Sharp & Dohme LLC
$190
E.R. Squibb & Sons, L.L.C.
$179
GlaxoSmithKline, LLC.
$167
Exelixis Inc.
$147
Seagen Inc.
$133
Gilead Sciences, Inc.
$97
GENZYME CORPORATION
$96
Karyopharm Therapeutics Inc.
$74
Pfizer Inc.
$69
Foundation Medicine, Inc.
$69
EISAI INC.
$63
Astellas Pharma US Inc
$62
Merck Sharp & Dohme Corporation
$61
Bayer HealthCare Pharmaceuticals Inc.
$61
Incyte Corporation
$60
Regeneron Healthcare Solutions, Inc.
$58
BeiGene USA, Inc.
$58
Lilly USA, LLC
$55
Eisai Inc.
$51
Stemline Therapeutics Inc.
$51
Pharmacyclics LLC, an AbbVie Company
$51
Genmab U.S., Inc.
$49
Coherus Biosciences Inc.
$45
Mirati Therapeutics, Inc.
$41
Deciphera Pharmaceuticals Inc.
$40
Alexion Pharmaceuticals, Inc.
$37
TESARO, Inc.
$36
Seattle Genetics, Inc.
$33
JAZZ PHARMACEUTICALS INC.
$33
CTI BioPharma Corp.
$27
Acrotech Biopharma Inc.
$27
PharmaEssentia USA Corporation
$26
Ipsen Biopharmaceuticals, Inc
$25
Pharmacyclics LLC, An AbbVie Company
$23
PUMA BIOTECHNOLOGY, INC.
$23
Takeda Pharmaceuticals U.S.A., Inc.
$22
Epizyme, Inc.
$22
Actelion Pharmaceuticals US, Inc.
$20
Bayer Healthcare Pharmaceuticals Inc.
$20
Verastem, Inc.
$19
ADC Therapeutics America, Inc.
$19
SECURA BIO, INC.
$18
EMD Serono, Inc.
$18
Helsinn Therapeutics (U.S.), Inc.
$17
ARRAY BIOPHARMA INC
$16
TerSera Therapeutics LLC
$16
AbbVie, Inc.
$15
Blueprint Medicines Corporation
$14
TG THERAPEUTICS, INC.
$14
Top 3 companies account for 23.6% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · ALOXI · AYVAKIT · Abraxane · Alecensa · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CHANTIX · COPIKTRA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · ELAHERE · EMPLICITI · ENHERTU · EPKINLY · Enhertu · Epkinly · FASLODEX · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · Gazyva · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · Neulasta · Nplate · OJJAARA · ONUREG · OPDIVO · Onivyde · Orserdu · PADCEV · PIQRAY · PROMACTA · Padcev · Perjeta · QINLOCK · REBLOZYL · RYBREVANT · RYZNEUTA · Revlimid · SARCLISA · Stivarga · TAGRISSO · TASIGNA · TUKYSA · Tazverik · Trodelvy · UKONIQ · ULTOMIRIS · UPTRAVI · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · Venclexta · Vonjo · XPOVIO · XTANDI · Xermelo · Xospata · ZEJULA · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
29
County median income
$79,431
Nearest hospital to ZIP centroid (approximate)
PIEDMONT CARTERSVILLE MEDICAL CENTER
5.4 mi
5.4 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mehta is a clinical cardiology specialist, with moderate Medicare volume, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mehta experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Mehta performed 191 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mehta receive payments from pharmaceutical companies?
Yes. Dr. Mehta received a total of $5,427 from 58 companies across 290 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mehta's costs compare to other hematology & oncology specialists in Cartersville?
Dr. Mehta's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mehta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Cartersville
Browse hematology & oncology specialists in Cartersville ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology